These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 15504832)

  • 1. Four variants of the Citrobacter freundii AmpC-Type cephalosporinases, including novel enzymes CMY-14 and CMY-15, in a Proteus mirabilis clone widespread in Poland.
    Literacka E; Empel J; Baraniak A; Sadowy E; Hryniewicz W; Gniadkowski M
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4136-43. PubMed ID: 15504832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution and spread of a multidrug-resistant Proteus mirabilis clone with chromosomal AmpC-type cephalosporinases in Europe.
    D'Andrea MM; Literacka E; Zioga A; Giani T; Baraniak A; Fiett J; Sadowy E; Tassios PT; Rossolini GM; Gniadkowski M; Miriagou V
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2735-42. PubMed ID: 21402851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of SXT/R391-like integrative and conjugative elements carrying blaCMY-2 in Proteus mirabilis.
    Mata C; Navarro F; Miró E; Walsh TR; Mirelis B; Toleman M
    J Antimicrob Chemother; 2011 Oct; 66(10):2266-70. PubMed ID: 21752830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CMY-16, a novel acquired AmpC-type beta-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy.
    D'Andrea MM; Nucleo E; Luzzaro F; Giani T; Migliavacca R; Vailati F; Kroumova V; Pagani L; Rossolini GM
    Antimicrob Agents Chemother; 2006 Feb; 50(2):618-24. PubMed ID: 16436718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.
    Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A
    Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway.
    Naseer U; Haldorsen B; Simonsen GS; Sundsfjord A
    Clin Microbiol Infect; 2010 Feb; 16(2):171-8. PubMed ID: 19548922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of CMY-4, an AmpC-type plasmid-mediated beta-lactamase in a Tunisian clinical isolate of Proteus mirabilis.
    Verdet C; Arlet G; Ben Redjeb S; Ben Hassen A; Lagrange PH; Philippon A
    FEMS Microbiol Lett; 1998 Dec; 169(2):235-40. PubMed ID: 9868767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC.
    Haldorsen B; Aasnaes B; Dahl KH; Hanssen AM; Simonsen GS; Walsh TR; Sundsfjord A; Lundblad EW
    J Antimicrob Chemother; 2008 Oct; 62(4):694-702. PubMed ID: 18583329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of multidrug-resistant Proteus mirabilis in a long-term care facility in Croatia.
    Bedenić B; Firis N; Elveđi-Gašparović V; Krilanović M; Matanović K; Štimac I; Luxner J; Vraneš J; Meštrović T; Zarfel G; Grisold A
    Wien Klin Wochenschr; 2016 Jun; 128(11-12):404-13. PubMed ID: 27220339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmid typing and genetic context of AmpC β-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes: findings from a Spanish hospital 1999-2007.
    Mata C; Miró E; Alvarado A; Garcillán-Barcia MP; Toleman M; Walsh TR; de la Cruz F; Navarro F
    J Antimicrob Chemother; 2012 Jan; 67(1):115-22. PubMed ID: 21980067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired AmpC type beta-lactamases: an emerging problem in Italian long-term care and rehabilitation facilities.
    Migliavacca R; Nucleo E; D'Andrea MM; Spalla M; Giani T; Pagani L
    New Microbiol; 2007 Jul; 30(3):295-8. PubMed ID: 17802913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasmid-mediated AMPc producing Proteus mirabilis in the Health Care Area of Santiago de Compostela: molecular and epidemiological analysis by rep-PCR and MALDI-TOF].
    Treviño M; Navarro D; Barbeito G; Areses P; García-Riestra C; Regueiro BJ
    Rev Esp Quimioter; 2012 Jun; 25(2):122-8. PubMed ID: 22707100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapidly spreading CTX-M-type beta-lactamase-producing Proteus mirabilis in Japan.
    Kanayama A; Iyoda T; Matsuzaki K; Saika T; Ikeda F; Ishii Y; Yamaguchi K; Kobayashi I
    Int J Antimicrob Agents; 2010 Oct; 36(4):340-2. PubMed ID: 20609568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissemination of the CTX-M-25 family beta-lactamases among Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae and identification of the novel enzyme CTX-M-41 in Proteus mirabilis in Israel.
    Navon-Venezia S; Chmelnitsky I; Leavitt A; Carmeli Y
    J Antimicrob Chemother; 2008 Aug; 62(2):289-95. PubMed ID: 18487232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristic of fluoroquinolone resistant clinical isolates of K. pneumoniae, P. mirabilis and E. coli producing ESBL and AmpC beta-lactamases].
    Rzeczkowska M; Piekarska K; Gierczyński R
    Med Dosw Mikrobiol; 2012; 64(4):285-95. PubMed ID: 23484420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and spread of carbapenem-resistant Citrobacter freundii in a teaching hospital in China.
    Chen S; Hu F; Liu Y; Zhu D; Wang H; Zhang Y
    Am J Infect Control; 2011 Nov; 39(9):e55-60. PubMed ID: 21705111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of extended-spectrum beta-lactamases in Proteus mirabilis in a Taiwanese university hospital, 1999 to 2005: identification of a novel CTX-M enzyme (CTX-M-66).
    Wu JJ; Chen HM; Ko WC; Wu HM; Tsai SH; Yan JJ
    Diagn Microbiol Infect Dis; 2008 Feb; 60(2):169-75. PubMed ID: 17913434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CMY-2-type plasmid-mediated AmpC ß-lactamases emerging in Tucumán, Argentina].
    Jure MA; Presti C; Cudmani NM; Grellet LM; López C; Musa EH; Aulet OC; Nieto C; Saavedra L; de Castillo MC
    Rev Argent Microbiol; 2011; 43(1):24-7. PubMed ID: 21491062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of a cefepime- and cefpirome-resistant Citrobacter freundii clinical isolate harbouring a novel chromosomally encoded AmpC beta-lactamase, CMY-37.
    Ahmed AM; Shimamoto T
    Int J Antimicrob Agents; 2008 Sep; 32(3):256-61. PubMed ID: 18619820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Beta-lactamases in Faecal Enterobacteriaceae Recovered from Healthy Humans in Spain: Focusing on AmpC Polymorphisms.
    Porres-Osante N; Sáenz Y; Somalo S; Torres C
    Microb Ecol; 2015 Jul; 70(1):132-40. PubMed ID: 25501887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.